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H I G H L I G H T S
• Murine self-absorbed S values.
• Dosimetry using MOBY phantom.
• Dosimetry of 99mTc, 67Ga, 68Ga, 18F, 223Ra, 166Ho, 90Y, 161Tb 131I and 177Lu.
• Radiation transport was performed with GATE/Geant4 platform.






A B S T R A C T
The aim of this work was to calculate S values for 99mTc, 67Ga, 68Ga, 18F, 223Ra, 166Ho, 90Y, 161Tb 131I and 177Lu,
using a mouse phantom (MOBY) standard and considering the anatomic sizes from males and females, the
simulation of radiation transport was performed with GATE/Geant4 platform. This indicates that in the internal
dosimetry the use of a customized geometry is relevant for each gender and a standard model is not a good
choice.
1. Introduction
Small animals such as rodents have been used for preclinical pur-
poses when new radiopharmaceuticals are developed prior the appli-
cation in humans, to study several diseases in its natural state. Rodents
as rats and mice are widely used in preclinical research studies to de-
velop and test new treatments and imaging methods for human diseases
(Gangadaran et al., 2018; Hindorf et al., 2004; Pet et al., 2007; Tuveson
and Hanahan, 2011; Vieyra-Reyes et al., 2017). Mice were not used
only with experimental purpose, also they have been used as model in
ionizing radiation dosimetry and imaging, there are a lot of examples
(Taschereau and Chatziioannou, 2007). Taschereau et al. mentioned
that is important to quantify accurately the absorbed dose in organs
because the effects on a given investigation are hard to predict; how-
ever, investigators should be aware of potential perturbations especially
when the studied organ receives high absorbed dose and when long-
itudinal imaging protocols are considered (Taschereau and
Chatziioannou, 2007). In this context, the most common method for
calculating the absorbed dose to a target region from ionizing radiation
emitted from a source region is by Medical Internal Radiation Dose
(MIRD) formalism, where absorbed dose is defined as
= ←D A S r r˜ . ( )h k h , Ãh is the cumulated activity in source region and
←S r r( )k h [Gy/Bq*s] is the S value. The absorbed dose per unit cu-
mulated activity was named S value by MIRD in 1965 and it is now very
well accepted for internal dosimetry. S values are generally calculated
for anatomic models with Monte Carlo method or dose kernels for both
animals and humans(Hindorf et al., 2004), because the dosimetry is
important in understanding the relationship between absorbed dose
and response, which can be translated to preclinical results for humans.
Several analytical phantoms have been considered as anatomic
models for the dosimetry which used ellipsoids, spheroids and cylinders
as organs, but the evolution of the graphic computing allows to create
more realistic mouse phantoms using structures very well defined with
the shape of a real organ even with movement such as respiratory
motion(Segars et al., 2004). In general, absorbed dose is geometry de-
pendent value, so the S value also, estimation of absorbed dose will be
more accurate in a mouse phantom with realistic structures (organs).
The use of realistic mouse phantoms as MOBY have been widely used
along with Monte Carlo simulations to compute reference dosimetric
quantities(Kolbert et al., 2003). The MOBY phantom was developed by
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Segars et al. (2004), it is an example of hybrid phantom, it is based on
non-uniform, rational B-spline surfaces, these surfaces allow flexibility
in the shapes of the organs, thirty-six regions and three skeletal regions
are segmented. The phantom is software controlled by a user-modified
parameter file and generates two sets of 3D voxel-based images with
specific matrix size of activity and attenuation in the mouse(Larsson,
2011). GEANT 4 is Monte Carlo code to perform ionizing radiation
transport, it was used to implement MOBY phantom in its platform
GATE(Jan et al., 2004; Taschereau and Chatziioannou, 2007), also
MOBY phantom has been implemented in MCNPX v2.7 for preclinical
assessments of radiopharmaceuticals (Mohammadi and Kinase, 2011).
The Gallium-67 (67Ga) citrate is widely used as a diagnostic agent of
inflammation, infection, cancer, iron deficiency, etc.(Tsan and Scheffel,
1986)(Marti et al., 2011)(Upadhyay et al., 2015)(Vieyra-Reyes et al.,
2017). Positron emitters as 18F and 68Ga are also used in small la-
boratory rodents to visualize and track molecular processes associated
with diseases such as cancer, heart disease and neurological disorders in
living small animal models of disease(Dam et al., 2016)(Xie and Zaidi,
2013). Lutetium-177 (177Lu) has been widely used as a theragnostic
radionuclide, because its medium energy β and gamma emission for
pretreatment imaging. Terbium-161 (161Tb) has β emission similar to
that of 177Lu, it seems to be a promising therapeutic radionuclide
(Champion et al., 2016), also Holmium-166 (166Ho) has been used in
targeted therapy. Currently, targeted alfa particle therapy is rapidly
developing, it is useful to the irradiation of fewer cancer cells, micro-
metastases or tumors by an emission of a single alpha particle or by a
cascade of heavy alpha particles from close vicinity(Kozempel et al.,
2018), the alfa particle emitter Radium-223 (223Ra) has demonstrated
to be useful for bone metastases treatment on patients with resistant
prostate cancer (Loizaga-Iriarte et al., 2018).
Nevertheless, many diseases specifically affect women or men, this
implies that preclinical studies must performed in female or male an-
imal models, in order to ensure accurate dosimetry, it is important to
consider the gender due to the influence of the mass, shape and the
distances between organs in calculating of S values. For above, the aim
of this work was to calculate S values for 99mTc, 67Ga, 68Ga, 18F, 223Ra,
166Ho, 90Y, 161Tb 131I and 177Lu, using a mouse phantom (MOBY)
standard and considering the anatomic sizes from males and females,




The study was conducted in accordance with approved institutional
protocols in agreement with the Principles and Procedures described by
the National Institute of Health, Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health, in accordance
with the Local Ethics Committee(Ochoa Muñoz, 1999). 12 CD-1 mice
were used, in two groups: 6 females and 6 males. They were maintained
in standard conditions of the animal facility: water and food at a free
demand, 50–55% of humidity, temperature set to 22 ± 2 °C, a 12:12
light/dark cycle was used, where light was turned on at 6 o'clock. At 12
weeks old, they were euthanized by CO2 inhalation method to minimize
suffering. Then, heart, spleen, kidneys and liver from each test subject
of the female group (FG) and the male group (MG) were dissected,
those organs were weighted, and the average mass of each organ was
obtained for FG and MG.
2.2. MOBY models and GATE/GEANT4
Using the organ mass obtained and multiplying with its corre-
sponding density from GateMaterials data base, new organ volumes
were calculated and rescaled in the parameter file of MOBY software.
Then, two models were created: female model (FM) and male model
(MM), besides the original phantom. All three models were exported in
a 256× 256 x 739 voxel phantom to perform the simulation and to
obtain the S value for each mentioned organ for 99mTc, 67Ga, 68Ga, 18F,
223Ra, 166Ho, 90Y, 161Tb, 131I and 177Lu. The source and target were
defined as a voxels group corresponding to its range of Hounsfield's
units (RHU) in Attenuation Map of MOBY. The source was uniformly
distributed inside each organ. Simulations were performed with GATE
version 8.1, which is based on Monte Carlo code Geant4 version 10.01
p02, radiation transport was performed with the compressed matrix
navigation method, because it is the best way to perform the simulation
with low computing resources. GATE generates the simulation results in
an image file that contains the information of Deposited Energy in each
voxel (detector) inside the region of interest and unused values in the
remain voxels of the phantom, all detectors had to be segmented using a
mask developed in ImageJ to calculate the deposited energy in the re-
gion of interest (ROI).
2.3. Dosimetry
The absorbed dose in a source-target organ depends on the amount
of cumulated activity (Ãh) and S-value, as described in MIRD scheme,
where the absorbed dose is defined as:
= ←D A S r r˜ . ( )h k h (1)
In general, ←S r r( )k h is the absorbed energy per mass unit in the
target organ rk by the decay of the radionuclide present in the source
organ rh, but in this work source region is the target region. The S values














Where Edep is the value in MeV of the energy deposited obtained by the
Monte Carlo simulation, ni is the number of particles per decay and mt
is the mass of the target organ(Kolbert et al., 2003).
The organ S-values were compared model to model, to get the
Percentage Change (PC) between them for all three voxel models, where









where Vf and Vi are final and initial values respectively, for changes
male to female (m → f), Vf is for female and Vi is for male, and so on for
male to MOBY (m → M) and female to MOBY (f → M).
The PC between absorbed doses were also analyzed to determine the
importance of performing dosimetric calculations with the appropriate
geometry for each gender, where initial radioactivity equal to 1Bq was
used to obtain the cumulated activity.
2.4. Computing resources
Calculations were performed using a Intel Xeon 4-core, RAM 16 GB;
archiving system 2 TB and the image segmentation and post processing
with Inter i7 Quad core @2.6 GHz, RAM 16 GB, archiving system 2 TB
and a video card Radeon Graphics.
3. Results
3.1. Organ masses
The average weight of the heart, spleen, kidneys and liver was
found, their average values are shown in Table 1. A major difference
between two models was found in kidneys and liver, a lighter difference
in the spleen and similar dimensions in heart.
The MOBY's parameter file allows changes to be made to any “vol-
organ parameter” or “whole body parameter”. The “vol-heart”, “vol-
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spleen”, “vol-kidney” and “vol-liver” parameters were modified and
kept the rest of the organs without changes.
3.2. Simulation
During the simulation, GATE converts the HU values to the Geant4
material compositions to calculate the deposited energy within the
voxels that share the same material composition and have an attached
voxel detector, that resulting deposited energy is a consequence of the
hits of the particles that released their energy in those voxels, as shown
in Fig. 1, then it is necessary to perform a segmentation of voxels with a
HU range defined for tissue of interest.
The output is an Image file that had to be post processed in order to
separate the information of the region of interest, a mask with the same
dimensions of the region of interest was implemented for each organ
using ImageJ, then S values for each organ was obtained.
3.3. S values
S values for ten radionuclides were obtained for each organ for all
three models, those values are shown in Table 2.
According to Table 2, for each radionuclide the effect on the S value
of the organ mass is noticeable, the magnitude of this effect depends on
the organ.
3.4. Dosimetry
As well as the S values, the absorbed dose was obtained and pre-
sented in Table 3. The PC in absorbed dose (D) values were not as in the
S values, because D also depends on half-life of radionuclides.
In order to verify the effect of the scaling of the organs in the
phantoms on the absorbed dose a comparison between the three models
was made, there was noticed that the organs with a major mass dif-
ference such as the kidneys and the liver present a major dispersion in
the PC.
4. Discussion
The S values are necessary to obtain the internal absorbed dose
according to eq. (1), so other works have reported S values for different
radionuclides and sizes of mouse phantoms(Bitar et al., 2007a, 2007b;
Kostou et al., 2016; Taschereau and Chatziioannou, 2007)(Xie and
Zaidi, 2013), in order to assess the potential of new radio-
pharmaceuticals. Nevertheless, to perform a more accurate dosimetry it
Table 1
Comparison of organ weight in mice from females and males groups.
Females Heart Spleen Kidneys Liver
Average [g]: 0.2370 ± 0.0290 0.2049 ± 0.04877 0.2704 ± 0.02538 2.4551 ± 0.3175
Males Heart Spleen Kidneys Liver
Average: [g] 0.2372 ± 0.2030 0.1791 ± 0.01794 0.4040 ± 0.0563 3.112 ± 0.2849
Fig. 1. Simulations results showing hits in the region of interest.
Table 2
S values for different radionuclides for three mouse models.
Organ Model
S values ( )GyBq s.
67Ga 68Ga 18F 131I 99mTc 90Y 223Ra 166Ho 177Lu 161Tb
Kidneys Male 1.06E-06 3.41E-12 6.29E-11 3.48E-11 3.42E-11 1.49E-10 1.59E-10 3.01E-11 5.35E-11 6.16E-11
Female 2.19E-06 3.65E-12 1.65E-10 5.87E-11 6.94E-11 3.84E-10 2.34E-10 2.12E-11 2.89E-11 3.39E-11
MOBY 2.75E-06 4.08E-12 1.77E-10 5.93E-11 7.19E-11 4.05E-10 2.66E-10 1.84E-11 1.55E-11 3.28E-11
Spleen Male 1.85E-09 3.88E-14 1.81E-10 1.88E-10 8.18E-11 4.03E-10 3.90E-10 8.93E-11 1.39E-10 1.65E-10
Female 1.69E-09 4.05E-14 1.75E-10 1.54E-10 7.94E-11 3.96E-10 3.92E-10 8.96E-11 1.45E-10 1.66E-10
MOBY 1.54E-09 4.01E-14 1.78E-10 1.60E-10 8.03E-11 3.98E-10 3.93E-10 8.95E-11 1.44E-10 1.69E-10
Liver Male 2.62E-10 3.20E-11 1.42E-11 6.54E-13 6.40E-14 4.06E-11 3.66E-11 7.49E-12 3.45E-13 2.17E-11
Female 3.20E-10 3.63E-11 1.62E-11 7.49E-13 7.56E-14 4.66E-11 2.94E-11 6.34E-12 2.33E-13 2.04E-11
MOBY 2.94E-10 3.59E-11 1.58E-11 7.52E-13 7.61E-14 4.75E-11 2.89E-11 6.26E-12 1.97E-13 1.96E-11
Heart Male 1.55E-09 1.33E-10 7.75E-11 8.74E-11 9.85E-11 1.96E-10 1.66E-10 3.65E-11 7.88E-11 6.65E-11
Female 1.55E-09 1.32E-10 7.73E-11 8.72E-11 9.78E-11 1.98E-10 1.67E-10 3.67E-11 7.85E-11 6.60E-11
MOBY 1.48E-09 1.31E-10 7.72E-11 8.69E-11 7.65E-11 2.04E-10 1.64E-10 3.69E-11 7.84E-11 6.61E-11
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is necessary to use real masses and volumes of organs because the
variation of S value is dependent of organ mass. In the previously re-
ported data, organ weights were obtained by resizing the entire
phantom(Keenan et al., 2010; Xie and Zaidi, 2013), but these are not
corresponding to the real masses of CD-1 mice obtained in this work.
The mass difference between 35 g MOBY model and our female mouse
phantom (34.4 g) was 30, 23, 37 and 22.5% for heart, spleen, kidneys
and liver respectively, even when both models have almost the same
weight.
The validation of our GATE/GEANT4 code domain was performed
by running a simulation with a 30 g whole body mouse model (MOBY)
and comparing the results with the S values reported by (Keenan et al.,
2010; Kostou et al., 2016) for fluorine-18 because this radionuclide is
defined as standard in the GATE libraries, the self-absorbed S values
results seem to be in good agreement with differences varying between
3 and 7%.
The self-absorbed S values for heart, spleen, kidneys and liver in the
female-(34.4 g), male-(40 g) and MOBY(35 g) phantom models present
changes among them due to the volume variations described above.
These changes are more noticeable in the kidneys and liver (Table 2).
For (m → f) comparison, the S values for the liver have Percentage
Changes up to 32.4% for 177Lu, considering the ten radionuclides an
average Percentage Change (PC) of 17.05 ± 6.9 was obtained. In kid-
neys a PC up to 162.32% for 18F and 157.71% for 90Y was found, even
when they are radionuclides for diagnosis and treatment respectively.
In this case an average PC of 77.29 ± 53.16 was obtained.
Regarding the changes between MOBY standard phantom with fe-
male and male models, it was observed that MOBY and the female
model have similar volumes and masses organ and whole body,
therefore calculating changes female to MOBY (f → M) the percentage
changes are smaller than changes male to MOBY (m → M). In ac-
cordance with eq. (1), the dosimetric percentage changes remain as
those of the S values.
It is worth mentioning that the biggest difference between the fe-
male and male models predominates, this indicates that in the internal
dosimetry the use of a customized geometry is relevant for each gender
and a standard model is not a good choice because there can be errors
greater than 100% when performing dosimetry.
5. Conclusions
The size organ differences between male and female phantoms can
not be obtained only by rescaling the whole MOBY phantom, it is ne-
cessary to rescale organ by organ, keeping the full phantom size fixed.
The effect on the dosimetry of the organ size within a voxel phantom
was investigated, using three models representing mass differences of
the organs between females and males CD-1 mice and the standard
MOBY model (35 g). The geometry impact on the self-absorbed S value
can produce errors greater than 100% in the dosimetric calculations,
this indicates that in the internal dosimetry the use of a customized
geometry is relevant for each gender and a standard model is not a good
choice.
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